Trump Announces Pfizer Deal & TrumpRx — Interactive Analysis Trump Announces Pfizer Deal & TrumpRx — Interactive Analysis Ready-to-publish HTML with interactive charts, an infographic explaining TrumpRx vs the PBM model, and placeholders to swap in verified data. Jump to Visuals Executive Summary On September 30, 2025, the administration announced a deal with Pfizer to lower prices for Medicaid and unveiled a government-backed direct-to-consumer portal called TrumpRx . This page includes charts you can update with official data (RAND, CMS, Pfizer releases) and a clear infographic showing how TrumpRx could bypass pharmacy benefit managers (PBMs). Visuals & Interactive Charts Each chart below contains sample placeholder data. Replace the arrays labeled REPLACE_WITH_REAL_DATA in the script tag with verified numbers. Chart 1 — Bra...
Markets Rally on Fed Rate-Cut Hopes: What Weak U.S. Jobs Data Really Means for Stocks, Bonds, and Your Portfolio - Dr. Sanjay kumar pawar Weak U.S. jobs data sharpened expectations the Federal Reserve will cut rates soon—sending stocks up and bond yields down. This in-depth analysis breaks down the data, explains the market mechanics, shows where opportunities and risks lie, and answers common investor questions. Sources: BLS, Federal Reserve, CME, Reuters, Bloomberg, U.S. Treasury. Table of Contents Executive Summary What Just Happened: The Data That Moved Markets Why “Bad News” Sparked a Rally: The Rate-Cut Transmission Mechanism The Bond Market’s Signal: Yields, Term Premiums, and Duration Equities Playbook: Who Benefits—And Who Doesn’t The Dollar, Credit, and Commodities: Second-Order Effects What the Fed Has Said (and Not Said) Key Charts & Data Table Risks to the Rally: Three Things That Could Upend the Narrative Actionable Takeaways FAQ Conclusion...